Armata Pharmaceuticals, Inc
Price
FilingsNewest: 8-K, Other eventsSep 23 →InsidersNo open-market buys or sales.→HoldersMadison 5.7%BlackRock 1.5%Vanguard 1.3%→Financing →PeersClosest companies: ENTA, ACXP, AZTR→
From the filings
Figures
- Net income
- −$192.2Mlast 12 months
- Operating cash flow
- −$24.0Mlast 12 months
- Cash and equivalents
- $24.0Mat the last balance sheet
- Shares outstanding
- 37.1M shareson issue